Trexquant Investment LP Intellia Therapeutics, Inc. Transaction History

Trexquant Investment LP

$8.35 Billion
Q2 2025

A detailed history of Trexquant Investment LP transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 1,127,331 shares of NTLA stock, worth $12.2 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,127,331

Previous 604,696 86.43%

Holding current value

$12.2 Million

Previous $4.3 Million 145.96%

% of portfolio

0.13%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$6.28 - $9.67 $3.28 Million - $5.05 Million	522,635 Added 86.43%	1,127,331 $10.6 Million
Q1 2025 May 14, 2025	SELL	$7.11 - $12.8 $447,474 - $805,580	-62,936 Reduced 9.43%	604,696 $4.3 Million
Q4 2024 Feb 12, 2025	BUY	$11.41 - $21.09 $7.62 Million - $14.1 Million	667,632 New	667,632 $7.78 Million
Q2 2024 Aug 13, 2024	BUY	$20.02 - $27.22 $3.42 Million - $4.65 Million	170,828 New	170,828 $3.82 Million
Q3 2022 Nov 14, 2022	BUY	$53.92 - $71.7 $1.43 Million - $1.9 Million	26,551 New	26,551 $1.49 Million
Q4 2021 Feb 14, 2022	SELL	$100.76 - $138.36 $1.17 Million - $1.6 Million	-11,596 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$132.37 - $176.78 $1.53 Million - $2.05 Million	11,596 New	11,596 $1.56 Million
Q2 2021 Aug 12, 2021	SELL	$60.88 - $161.91 $760,573 - $2.02 Million	-12,493 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$46.59 - $83.68 $582,048 - $1.05 Million	12,493 New	12,493 $1 Million
Q4 2020 Feb 11, 2021	SELL	$18.83 - $63.53 $842,698 - $2.84 Million	-44,753 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$17.47 - $24.93 $172,446 - $246,084	9,871 Added 28.3%	44,753 $890,000
Q2 2020 Aug 07, 2020	BUY	$11.14 - $22.87 $104,504 - $214,543	9,381 Added 36.79%	34,882 $733,000
Q1 2020 May 08, 2020	BUY	$9.44 - $15.58 $99,695 - $164,540	10,561 Added 70.69%	25,501 $312,000
Q4 2019 Feb 12, 2020	BUY	$10.43 - $17.67 $25,970 - $43,998	2,490 Added 20.0%	14,940 $219,000
Q3 2019 Nov 08, 2019	BUY	$13.07 - $18.51 $14,285 - $20,231	1,093 Added 9.62%	12,450 $166,000
Q2 2019 Aug 09, 2019	BUY	$13.88 - $18.41 $157,635 - $209,082	11,357 New	11,357 $186,000
Q3 2018 Nov 09, 2018	SELL	$25.78 - $32.6 $523,359 - $661,812	-20,301 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$20.02 - $30.79 $406,426 - $625,067	20,301 New	20,301 $555,000

Others Institutions Holding NTLA

# of Institutions

333

Shares Held

96.5M

Call Options Held

1.76M

Put Options Held

1.05M

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $825M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Intellia Therapeutics, Inc. Transaction History